Clinical trial
Von Hippel-Lindau Disease Genetic Epidemiology Study
NCT00001803 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00001803 |
|---|---|
| Title | Von Hippel-Lindau Disease Genetic Epidemiology Study |
| Official title | Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Study type | Observational |
| Conditions | Von Hippel Lindau Disease, Kidney Neoplasms |
| Enrollment | 546 |
| Start date | Feb 26, 1999 |
| Primary completion | Jan 9, 2020 |
| Completion | Jan 9, 2020 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 13, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: